Indeed, CAV1 has been associated with tumor progression in PCa and the CAV1-induced inhibition of PP1 activity seems to contribute to its tumor promoter role, highlighting the potential of this complex as a drug target [7,58]. Here, CAV1 is linked to posterior cortical atrophy.